CBI Profile Overview  |  Investment Focus  |  Investment Strategy CBI's investement focus concentrates on proprietary technological platforms and innovative biopharmaceutical products to unmet needs and significant markets. A CBI portfolio company is distinguished by: Development stage: at least pre-clinical Geography: preference to companies based in Israel Seasoned, motivated management team IP: potential or existing long-term, extensive patent protection Relevant regulatory environment Sound business model   Home | Profile | Team | Portfolio | Contact Us | Disclaimer All Rights Reserved to Clal Biotechnology Industries Ltd.